Table 1.
Multivariable model predicting receipt of at least 300 days of hydroxyurea among children with SCA with evidence of hydroxyurea use (N=4370 person-years).
Predictor | Odds Ratio | 95% Confidence Interval | P-Value |
---|---|---|---|
Inpatient Visits | 0.77 | 0.73, 0.81 | <0.0001 |
ED Visits | 1.01 | 0.99, 1.04 | 0.1982 |
Outpatient Visits | 1.01 | 1.00, 1.02 | 0.0018 |
Age | 0.93 | 0.91, 0.94 | <0.0001 |
Sex | |||
Male | Reference | Reference | Reference |
Female | 0.92 | 0.78, 1.08 | 0.2803 |
State | |||
Illinois | Reference | Reference | Reference |
Michigan | 1.12 | 0.83, 1.50 | 0.4635 |
Louisiana | 0.93 | 0.71, 1.24 | 0.6339 |
South Carolina | 0.55 | 0.39, 0.79 | 0.0010 |
Texas | 0.78 | 0.59, 1.03 | 0.0754 |
Florida | 0.96 | 0.74, 1.24 | 0.7567 |
Year | |||
2005 | Reference | Reference | Reference |
2006 | 0.85 | 0.59, 1.22 | 0.3861 |
2007 | 0.90 | 0.63, 1.29 | 0.5669 |
2008 | 0.93 | 0.65, 1.32 | 0.6683 |
2009 | 0.67 | 0.47, 0.97 | 0.0311 |
2010 | 0.80 | 0.57, 1.12 | 0.1944 |
2011 | 0.69 | 0.49, 0.96 | 0.0273 |
2012 | 0.64 | 0.46, 0.89 | 0.0076 |